Please try another search
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
Name | Age | Since | Title |
---|---|---|---|
Scott Rodeo | - | - | Member of Clinical Advisory Board |
Patrick T. O'Donnell | 59 | 2021 | Independent Director |
Brent Henry-Barry Norton | 63 | 2016 | Director |
Caroline Hoemann | 64 | 2015 | Member of Scientific Advisory Board |
Jacques Toueg | - | 2018 | Member of Clinical Advisory Board |
Pierre Laurin | 63 | 2019 | Interim CEO & Independent Chairman |
Martyn Snow | - | - | Member of Clinical Advisory Board |
Steven Saviuk | 65 | 2015 | Director |
Jack Farr | - | - | Member of Clinical Advisory Board |
Howard P. Walthall | 52 | 2021 | Independent Director |
Timothy M. Cunningham | 61 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review